Effects of Pregnane X Receptor Genetic Polymorphisms on Stable Warfarin Doses
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Pregnane X Receptor Genetic Polymorphisms on Stable Warfarin Doses
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 20, Issue 6, Pages 532-538
Publisher
SAGE Publications
Online
2015-04-07
DOI
10.1177/1074248415578906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses
- (2015) Jung Yeon Moon et al. Pharmacogenetics and Genomics
- Impact of GATA4 variants on stable warfarin doses in patients with prosthetic heart valves
- (2014) E Jeong et al. PHARMACOGENOMICS JOURNAL
- A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
- (2014) Jinxing Chen et al. PLoS One
- Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
- (2013) Talitha I. Verhoef et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Post-translational and Post-transcriptional Modifications of Pregnane X Receptor (PXR) in Regulation of the Cytochrome P450 Superfamily
- (2013) Tomas Smutny et al. CURRENT DRUG METABOLISM
- Nuclear receptors in the cross-talk of drug metabolism and inflammation
- (2013) Sabine Gerbal-Chaloin et al. DRUG METABOLISM REVIEWS
- Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients
- (2013) Sin-Chi Chew et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond
- (2013) Xiaojuan Chai et al. Expert Opinion on Drug Metabolism & Toxicology
- The Transcriptional Regulation of the Human CYP2C Genes
- (2012) Yuping Chen et al. CURRENT DRUG METABOLISM
- Role of CAR and PXR in xenobiotic sensing and metabolism
- (2012) Yue-Ming Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients
- (2012) Ruijuan Liang et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Effects of CYP4F2 Gene Polymorphisms on Warfarin Clearance and Sensitivity in Korean Patients With Mechanical Cardiac Valves
- (2012) Kyung-Eun Lee et al. THERAPEUTIC DRUG MONITORING
- Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients
- (2011) Shi-Long Zhong et al. Pharmacogenetics and Genomics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- Nuclear Receptor Coactivator 6 Mediates the Synergistic Activation of Human Cytochrome P-450 2C9 by the Constitutive Androstane Receptor and Hepatic Nuclear Factor-4
- (2008) S. Surapureddi et al. MOLECULAR PHARMACOLOGY
- Warfarin Pharmacogenetics
- (2008) Nita A Limdi et al. PHARMACOTHERAPY
- The Tangle of Nuclear Receptors that Controls Xenobiotic Metabolism and Transport: Crosstalk and Consequences
- (2007) Jean-Marc Pascussi et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search